A modified method using the SonoPrep® ultrasonic skin permeation system for sampling human interstitial fluid is compatible with proteomic techniques

Skin Research and Technology

Volumn 19, Issue 1, 2013, Pages 27-34

  Lecomte, Marie M J ^a,b   Atkinson, Kelly R ^c   Kay, Daniel P ^d   Simons, Joanne L ^a   Ingram, John R ^c  

^a MT ALBERT RESEARCH CENTRE   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^d INSTITUTE OF ENVIRONMENTAL SCIENCE AND RESEARCH   (New Zealand)

Author keywords

Biomarkers; Interstitial fluid; Micropores; Proteins; Proteomic techniques; Skin; SonoPrep ultrasonic skin permeation system; Stratum corneum

Indexed keywords

INTERSTITIAL FLUIDS; MICROPORES; PROTEOMIC TECHNIQUES; SKIN PERMEATION; STRATUM CORNEUM;

BIOMARKERS; ELECTROPHORESIS; MICROPOROSITY; PROTEINS; SKIN; TWO DIMENSIONAL;

ULTRASONIC TESTING;

MEMBRANE PROTEIN;

ADULT; ARTICLE; EPIDERMIS; FEMALE; HUMAN; IMAGE ANALYSIS; INTERSTITIAL FLUID; MALE; MICROSPORE; MINIMALLY INVASIVE PROCEDURE; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEOMICS; SKIN PERMEABILITY; STRATUM CORNEUM; TWO DIMENSIONAL GEL ELECTROPHORESIS; ULTRASOUND; WESTERN BLOTTING;

ADULT; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DERMATOLOGY; EPIDERMIS; EXTRACELLULAR FLUID; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEINS; PROTEOMICS; REFERENCE VALUES; SPECIMEN HANDLING; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; ULTRASONICS; VACUUM;

EID: 84872148644     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/j.1600-0846.2012.00641.x     Document Type: Article

References (15)

1. Celis JE, Gromov P, Cabezón T, Moreira JMA, Ambartsumian N, Sandelin K, Rank F, Gromova I. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment. Mol Cell Proteomics 2006; 3: 327-344.
2. Ahn SM, Simpson RJ. Body fluid proteomics: prospects for biomarker discovery. Proteomics Clin Appl 2007; 1: 1004-1015.
3. Gromov P, Gromova I, Bunkenborg J, Cabezon T, Moreria JM, Timmermans-Wielenga V, Roepstorff P, Rank F, Celis JE. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast. Mol Oncol 2010; 4: 65-89.
4. Stone MD, Odland RM, McGowan T, Onsongo G, Tang C, Rhodus NL, Jagtap P, Bandhakavi S, Griffin TJ. Novel in situ collection of tumor interstitial fluid from a head and neck squamous carcinoma reveals a unique proteome with diagnostic potential. Clin Proteomics 2010; 6: 75-82.
5. Huang CM. In vivo secretome sampling technology for proteomics. Proteomics Clin Appl 2007; 1: 953-962.
6. Nindl BC, Tuckow AP, Alemany JA, Harman EA, Rarick KR, Staab JS, Faupel ML, Khosravi MJ. Minimally invasive sampling of transdermal body fluid for the purpose of measuring insulin-like growth factor-I during exercise training. Diabetes Technol Ther 2006; 8: 244-252.
7. Kool J, Reubsaet L, Wesseldijk F, Maravilha RT, Pinkse MW, D'Santos CS, van Hilten JJ, Zijlstra FJ, Heck AJ. Suction blister fluid as potential body fluid for biomarker proteins. Proteomics 2007; 7: 3638-3650.
8. Castillo CE, Lillioja S. Peripheral lymphatic cannulation for physiological analysis of interstitial fluid compartment in humans. Am J Physiol Heart Circ Physiol 1991; 261: H1324-H1328.
9. Farinha A, Kellogg S, Dickinson K, Davison T. Skin impedance reduction for electrophysiology measurements using ultrasonic skin permeation: inital report and comparison to current methods. Biomed Instrum Technol 2006; 39: 72-77.
10. Meng Z, Veenstra TD. Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers. Proteomics Clin Appl 2007; 1: 747-757.
11. Gill C, Parkinson E, Church MK, Skipp P, Scott D, White AJ, O'Connor CD, Clough GF. A qualitative and quantitative proteomic study of human microdialysate and the cutaneous response to injury. AAPS J 2011; 13: 309-317.
12. Knudsen LS, Hetland ML, Johansen JS, Skjødt H, Peters ND, Colic A, Grau K, Nielsen HJ, Ostergaard M. Changes in plasma IL-6, plasma VEGF and serum YKL-40 during treatment with etanercept and methotrexate or etanercept alone in patients with active rheumatoid arthritis despite methotrexate therapy. Biomark Insights 2009; 4: 91-95.
13. Ghahary A, Marcoux Y, Karimi-Busheri F, Li Y, Tredget EE, Kilani RT, Lam E, Weinfeld M. Differentiated keratinocyte-releasable stratifin (14-3-3 Sigma) stimulates MMP-1 expression in dermal fibroblasts. J Invest Dermatol 2005; 124: 170-177.
14. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
15. Enzi G, Gasparo M, Biondetti PR, Fiore D, Semisa M, Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am J Clin Nutr 1986; 44: 739-746.